My reviews
Where I see patients (1)
Selected research
-
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.
Blood
-
BCMA-directed CAR T-cell Therapy in patients with multiple myeloma and CNS involvement.
Blood advances
-
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.
Blood advances
Clinical trials
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With D...
DLTs will be based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 5.0 and will include most grade 3 or higher events, as defined in the protocol.
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9